[go: up one dir, main page]

RU2018142908A3 - - Google Patents

Download PDF

Info

Publication number
RU2018142908A3
RU2018142908A3 RU2018142908A RU2018142908A RU2018142908A3 RU 2018142908 A3 RU2018142908 A3 RU 2018142908A3 RU 2018142908 A RU2018142908 A RU 2018142908A RU 2018142908 A RU2018142908 A RU 2018142908A RU 2018142908 A3 RU2018142908 A3 RU 2018142908A3
Authority
RU
Russia
Application number
RU2018142908A
Other versions
RU2764747C2 (ru
RU2018142908A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018142908A publication Critical patent/RU2018142908A/ru
Publication of RU2018142908A3 publication Critical patent/RU2018142908A3/ru
Application granted granted Critical
Publication of RU2764747C2 publication Critical patent/RU2764747C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/02General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0216Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Epoxy Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
RU2018142908A 2016-05-06 2017-05-05 Способ лечения рака уротелия нижних путей RU2764747C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662333151P 2016-05-06 2016-05-06
US62/333,151 2016-05-06
US201762443614P 2017-01-06 2017-01-06
US62/443,614 2017-01-06
PCT/US2017/031445 WO2017193098A1 (en) 2016-05-06 2017-05-05 Method of treating lower tract urothelial cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2022100624A Division RU2022100624A (ru) 2016-05-06 2017-05-05 Способ лечения рака уротелия нижних путей

Publications (3)

Publication Number Publication Date
RU2018142908A RU2018142908A (ru) 2020-06-08
RU2018142908A3 true RU2018142908A3 (ru) 2020-08-31
RU2764747C2 RU2764747C2 (ru) 2022-01-20

Family

ID=60203435

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2018142908A RU2764747C2 (ru) 2016-05-06 2017-05-05 Способ лечения рака уротелия нижних путей
RU2022100624A RU2022100624A (ru) 2016-05-06 2017-05-05 Способ лечения рака уротелия нижних путей

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2022100624A RU2022100624A (ru) 2016-05-06 2017-05-05 Способ лечения рака уротелия нижних путей

Country Status (23)

Country Link
US (1) US20190388338A1 (ru)
EP (2) EP3452053B1 (ru)
JP (3) JP7712055B2 (ru)
KR (2) KR102435709B1 (ru)
CN (2) CN109475571A (ru)
AU (1) AU2017261371B2 (ru)
CA (1) CA3023274A1 (ru)
ES (1) ES2940227T3 (ru)
FI (1) FI3452053T3 (ru)
HR (1) HRP20221544T1 (ru)
HU (1) HUE060965T2 (ru)
IL (2) IL262746B (ru)
LT (1) LT3452053T (ru)
MX (2) MX389296B (ru)
NZ (3) NZ748252A (ru)
PL (1) PL3452053T3 (ru)
PT (1) PT3452053T (ru)
RS (1) RS64032B1 (ru)
RU (2) RU2764747C2 (ru)
SG (2) SG10201913416PA (ru)
SI (1) SI3452053T1 (ru)
SM (1) SMT202300047T1 (ru)
WO (1) WO2017193098A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201891093A1 (ru) 2015-11-03 2018-10-31 Янссен Байотек, Инк. Антитела, специфически связывающие pd-1, и их применение
AU2017343621B2 (en) 2016-10-11 2021-12-02 Agenus Inc. Anti-LAG-3 antibodies and methods of use thereof
SG11201913251VA (en) * 2017-07-25 2020-01-30 Taris Biomedical Llc Methods of treating tumor metastasis
CN111787926A (zh) 2017-11-08 2020-10-16 塔里斯生物医药公司 使用吉西他滨对膀胱癌进行治疗和维持疗法的方法
US12398209B2 (en) 2018-01-22 2025-08-26 Janssen Biotech, Inc. Methods of treating cancers with antagonistic anti-PD-1 antibodies

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30915A1 (es) * 2007-02-16 2008-09-02 Smithkline Beecham Corp Método de tratamiento de canceres
CA2765734C (en) 2009-06-26 2016-12-13 Taris Biomedical, Inc. Implantable drug delivery devices and methods of making the same
HRP20250946T1 (hr) 2009-12-17 2025-10-10 Taris Biomedical Llc Intravezikalno podnošljiv implantabilni uređaj
PH12012502378A1 (en) * 2010-06-02 2013-02-11 Abraxis Bioscience Llc Methods of treating bladder cancer
SMT202000670T1 (it) 2010-08-05 2021-01-05 Taris Biomedical Llc Dispositivo e kit di somministrazione di farmaci per stent ureterale
US9107816B2 (en) 2011-02-04 2015-08-18 Taris Biomedical Llc Implantable device for controlled dissolution and diffusion of low solubility drug
CN111420032A (zh) 2012-03-29 2020-07-17 阿尔托生物科学有限公司 用于治疗肿瘤的方法
SG11201501424SA (en) * 2012-08-31 2015-03-30 Taris Biomedical Llc Drug delivery systems and methods for treatment of bladder cancer comprising oxaliplatin
CN112516154A (zh) 2012-08-31 2021-03-19 塔里斯生物医药公司 用于治疗前列腺的药物递送系统和方法
EP2964310A1 (en) 2013-03-05 2016-01-13 TARIS Biomedical LLC Drug delivery devices and methods for controlled drug release through device orifice
EP2968880B1 (en) 2013-03-15 2025-04-30 TARIS Biomedical LLC Drug delivery devices with drug-permeable component
CA2902556C (en) 2013-03-15 2021-06-22 Heejin Lee Drug delivery devices and methods for drug delivery
IL299897B2 (en) 2013-08-19 2024-02-01 Taris Biomedical Llc Devices and methods for administering multiple units of drug
PT3113782T (pt) * 2014-03-06 2023-01-05 Taris Biomedical Llc Sistemas e métodos de administração de fármaco para tratamento do cancro da bexiga com gemcitabina
JP6856380B2 (ja) 2014-06-26 2021-04-07 タリス バイオメディカル エルエルシー 弾性ポリマー−薬物マトリックス系を含む膀胱内薬物送達デバイス及び方法
WO2016172704A1 (en) 2015-04-23 2016-10-27 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods

Also Published As

Publication number Publication date
SG11201809838VA (en) 2018-12-28
MX2021013461A (es) 2021-12-10
JP2022009327A (ja) 2022-01-14
NZ787824A (en) 2025-10-31
RU2764747C2 (ru) 2022-01-20
BR112018072551A2 (pt) 2019-02-19
HRP20221544T1 (hr) 2023-02-17
EP3452053B1 (en) 2022-12-14
KR20190005204A (ko) 2019-01-15
FI3452053T3 (fi) 2023-04-12
PT3452053T (pt) 2023-03-03
KR102435709B1 (ko) 2022-08-25
AU2017261371B2 (en) 2023-07-06
IL262746A (en) 2018-12-31
RS64032B1 (sr) 2023-04-28
JP2019514970A (ja) 2019-06-06
IL262746B (en) 2022-09-01
CA3023274A1 (en) 2017-11-09
NZ748252A (en) 2025-10-31
CN109475571A (zh) 2019-03-15
ES2940227T3 (es) 2023-05-04
RU2022100624A (ru) 2022-02-09
PL3452053T3 (pl) 2023-05-08
CN118453872A (zh) 2024-08-09
SI3452053T1 (sl) 2023-03-31
LT3452053T (lt) 2023-02-10
HUE060965T2 (hu) 2023-04-28
MX2018013432A (es) 2019-08-12
EP3452053A4 (en) 2019-12-25
IL295592A (en) 2022-10-01
MX389296B (es) 2025-03-20
JP2024028881A (ja) 2024-03-05
US20190388338A1 (en) 2019-12-26
JP7712055B2 (ja) 2025-07-23
KR20220123317A (ko) 2022-09-06
EP4209221A1 (en) 2023-07-12
SMT202300047T1 (it) 2023-03-17
RU2018142908A (ru) 2020-06-08
NZ787786A (en) 2025-10-31
EP3452053A1 (en) 2019-03-13
WO2017193098A1 (en) 2017-11-09
SG10201913416PA (en) 2020-03-30
AU2017261371A1 (en) 2018-12-13

Similar Documents

Publication Publication Date Title
BR112019009389A2 (ru)
RU2018142908A3 (ru)
BR112019006736A2 (ru)
CN303538695S (ru)
CN303701521S (ru)
CN303660936S (ru)
CN303641388S (ru)
CN303633636S (ru)
CN303629309S (ru)
CN303594858S (ru)
CN303571657S (ru)
CN303564491S (ru)
CN303556757S (ru)
CN303546509S (ru)
CN303539243S (ru)
CN303539140S (ru)
CN303539134S (ru)
CN303539132S (ru)
CN303539115S (ru)
CN303539080S (ru)
CN303539065S (ru)
CN303539004S (ru)
CN303538902S (ru)
CN303538889S (ru)
CN303538885S (ru)